What Is. Is the combination of two or more things to produce something that neither component could produce alone.

Size: px
Start display at page:

Download "What Is. Is the combination of two or more things to produce something that neither component could produce alone."

Transcription

1

2 What Is Is the combination of two or more things to produce something that neither component could produce alone. 1

3 Our Skills Synergy Swiss Pharma has an experienced team with collective knowledge and familiarity with the global pharmaceutical network, which puts them in a position to offer comprehensive assistance and to build long-term partnerships. S y n e r g y S w i s s P h a r m a provides product development and subsequent regulatory services for all companies entering the regulated markets worldwide. Close association with the world pharmaceutical industry, and has wellentrenched global contacts to offer top quality API s, Formulation & technology transfer, sourced from the best global manufacturing facilities, at competitive pricing. 2

4 Why Choosing Us? We ensures deliverance of a complete development package matching the requirements of the high qualified generic industry. Our services include guidance in launching products in regulated markets like Europe, Japan, Korea, Asia, Middle East, Australia and New Zealand. We provide regulatory documentation, technical assistance, patent research assistance and other allied services. 3

5 Our Products Synergy Swiss Pharma has been expanding into different types of sectors with full development of finished dosage forms including regulatory files (European level) till the marketing. The company is specialized in respiratory, cardiovascular, psychiatry, gastroenterology, ophthalmology. Injectable of all forms, slow and fast release with new applications. Pharma Synergy Swiss has been expanding into different types of sectors, Active Pharmaceutical Ingredient, Intermediate Development, Medical Devices & Food Supplement with the development thanks to internal IP Department able to support Paragraph IV submission and to market the most interesting molecules for the coming years supported by a strong and well experienced R&D team. 4

6 Our Products: Respiratory Line Available Active ingredient Strength Presentation Budesonide 1mg/2ml - 0.5mg/2ml 0.25mg/2ml 200 mcg/actuation suspension for nebulisation MDI Fluticasone 50 mcg/actuation nasal spray Mometasone 50mcg/actuation nasal spray Salbutamol + Ipratropium 2.5mg + 0.5mg/2.5ml Solution for nebulization Salmeterol + Fluticasone 25mcg + 125mcg 25mcg + 250mcg 50mcg + 250mcg 50mcg + 500mcg MDI DPI Oct 2014 Products available only from and to countries where there is no valid patent protection and according to the applicable law 5

7 Our Products: Respiratory Line Under Development Active ingredient Strength Presentation Fluticasone 0.5mg/2ml 2mg/2ml suspension for nebulisation Tiotropium 18 mcg/capsule DPI Oct 2014 Products available only from and to countries where there is no valid patent protection and according to the applicable law 6

8 Our Products: Ophthalmic Line Available Active ingredient Strength Presentation Dorzolamide + Timolol 20mg+5 mg/ml single-dose vial and dropper Latanoprost 50 mcg/ml single-dose vial and dropper Latanoprost + Timolol 50mcg + 5mg/ml single-dose vial and dropper Tobramycin 3 mg/ml single-dose vial and dropper, also for auricular use Tobramycin + Dexamethasone 3mg+1mg/ml Travoprost 40 mcg/ml dropper single-dose vial and dropper Oct 2014 Products available only from and to countries where there is no valid patent protection and according to the applicable law 7

9 Our Products: Food Line More than 90 product formulations developed Our products are selling successfully in multiple markets All our products are manufactured at GMP-approved facilities in Germany and Italy All our products are developed to maximise the marketing possibilities to end-consumer, based on the type of registration, patents, and of course ingredients Scientific innovations: GoldenCaps a novel, patented dietary supplement helping to prevent the progressions of Dementia and Alzheimer Dermolipase a novel, patented treatment for Cellulites Hyamira cross-linked Hyaluronic Acid for beauty treatments Novel Mechanisms: Lenidor BB a pre- & probiotic, with a novel mechanism significantly prolonging shelf- life and ensuing highlevel activity of the pre-biotic Simethicone Bi-layer a novel mechanism allowing simethicone to be active in the stomach as well as the intestine. A Medical Device indicated to treat swelling of the stomach (aerophagia) and intestine (bloating) due to the accumulation of gas Regulatory approvals: CE-Medical devices: Menopause Patch Medical Device containing natural herbs for the treatment of menopause symptoms CE-Medical device registrations allow our distributors to communicate directly the product benefits to the end consumers 8

10 Our Products: Food Line Gliris GoldenCaps Lenidor BB Asterias Condramin Liponorma Nutrivita Force Pre & Post Sport Gel Hyamira Hyaluronic Acid inj Vijoint Hyaluronic Acid Dermolipase No Crave Uractiv complex Uromaxiflow Salusgate Flu Cough & Cold Spray & Tablets 9

11 Our Products: Food Line Menopause Patch Heat Anti-Pain Patch Natural Anti-Inflammatory & Rheumatic pain-relief Patch Flatbelly Re-flux tablet Re-flux liquid Psyllium Intestinal transit and colon propulsion 10

12 Our Products: Anesthetic Product Strenght Presentation Pack Therapeutic indications ORAMORPH (oral liquid morphine sulphate) MORPHINE HYDROCLHORIDE 10mg/5ml 30mg/5ml 2mg/ml 20mg/ml 10mg/ml 20mg/ml 50mg/5ml Udv s Plastic unit dose vials Syrup 100ml bottle (child proof and doser) Solution 20ml bottle drop (child proof and dropper) 10, 20 and 30 udv s Severe chronic pain Predictable Break through cancer pain Injectable forms 1 and 5 amps Acute pain PETHIDINE 100mg/2ml Injectable forms 1 glass amp Moderate to severe pain DEPALGOS (Oxycodone+Paracet amol) 5mg/325mg 10mg/325mg 20mg/325mg Tablets 14, 28, 56 tablets Moderate to severe chronic pain of degenerative origin under muscle-ostearticular illness. 11

13 Our Products: Anesthesia Product Strenght Presentation Pack Therapeutic indications ROPIVACAINE (hydrochloride vials & infusion) 2mg/ml 7,5mg/ml 10mg/ml Amp 10ml 20ml/Bags 100, 200ml Amp 10ml, 20ml Amp 10ml, 20ml Pack of 5 plastic amp Local and general anesthesia (motor block) Acute pain post-operative KETAMINE 50mg/ml Injectable amp 2ml Pack of 1 glass amp Anesthetic for diagnostic and surgical procedure L-BUPIVACAINE 2,5mg/ml 5mg/ml 7,5mg/ml 0,625mg/ml 1,25mg/ml Ampoules 10ml Amp 10ml Amp 10ml Bag 100ml,200ml Bag 100ml,200ml Pack of 10 Local and general anesthesia (motor block) Acute pain post-operative 12

14 Our Products: Addiction Product METHADONE (oral liquid solution) Stren ght 1mg/ml 5mg/ml 10mg/ml Presentation Pack Therapeutic indications 100ml, 500ml, 1000ml Bottle Treatment of heroin drug addiction dependence LEVO-METHADONE (oral liquid solution) BUPRENORPHINE 5mg/ml 100ml, 500ml bottle Treatment of heroin drug addiction dependence 2mg 8mg Sublingual tablets 7 or 14 tablets Treatment of heroin drug addiction dependence NALTREXONE 50mg Oral tables 14 or 28 tablets Treatment of alcohol dependence and detoxification NALOXONE 0,4mg/ml 0,04 mg/2ml Injectable amp 1 glass amps Used to counteract lifethreatening depression of the central nervous system and respiratory system. 13

15 Our Products: we are specializes also in Biotechnological Products Antibiotics Oncologics Neuroleptics Anticoagulants Blood Derivates Cardiovasculars Ophthalmics Narcotics Antiviral drugs 14

16 Our Partners 15

17 Contacts Via Luigi Lavizzari 4, 6850 Mendrisio / Switzerland tel:+41 (0) fax: +41 (0) Marketing Department: marketing@synergypharma.ch Commercial Department: commercial@synergypharma.ch 16

Consumer Health Care V5.0_2013

Consumer Health Care V5.0_2013 Consumer Health Care Headquarters ProNovis GmbH Infanteriestr. 19/6 80797 Munich Germany Tel: +49 / 89 / 326676-30 Fax: +49 / 89 / 326676-35 www.pronovis.net info@pronovis.net Mission and Vision ProNovis

More information

Innova&ve Medical Devices, Nutraceu&cals & Cosmeceu&cals. Company presenta&on Q1/2015

Innova&ve Medical Devices, Nutraceu&cals & Cosmeceu&cals. Company presenta&on Q1/2015 Innova&ve Medical Devices, Nutraceu&cals & Cosmeceu&cals Company presenta&on Q1/2015 Who We Are The Ceu&cs Company develops and manufactures innova&ve: Nutraceu&cals Medical Devices Cosmeceu&cals We partner

More information

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement 67 Years of Leadership in Pharmacy A Journey of Continuous Improvement September 2012 GALENIKA A.D. IS The only Serbian state-owned pharmaceutical company Manufacturer of generic drugs its manufacturing

More information

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide.

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. INTERNATIONAL Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. Our vision Making Lives Better drives every action and decision of

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

NATIVA GROUP. Inspired by Innovation and Technology

NATIVA GROUP. Inspired by Innovation and Technology NATIVA GROUP Inspired by Innovation and Technology INNOVATION & TECHNOLOGY IS OUR PASSION Nativa is a leading group of pharmaceutical companies in Russia. It develops and produces worldclass complex medicines

More information

INTRODUCTORY TRAINING

INTRODUCTORY TRAINING INTRODUCTORY TRAINING Who is BioCeuticals & Why range them? BioCeuticals is Australian Owned and is a leading provider of nutritional and therapeutic supplements Renowned for manufacturing and delivering

More information

Medical Developments International

Medical Developments International Medical Developments International Vision Medical Developments International (MDI) is a leading Emergency Medicine Company. Our aim is to 1. Dominate the analgesic trauma and minor surgical procedures

More information

Sub-components in Nicotine cessation products?

Sub-components in Nicotine cessation products? Sub-components in Nicotine cessation products? Mr Arun Sarda, Director of Quality and Regulatory Affairs Member of the HEITKAMP & THUMANN GROUP Regulatory approval of sub-components in nicotine cessation

More information

Philippine Strategy for the. Free Alternatives. under the National CFC Phase-out Plan (NCPP)

Philippine Strategy for the. Free Alternatives. under the National CFC Phase-out Plan (NCPP) Philippine Strategy for the Transition from CFCcontaining MDIs to CFC- Free Alternatives under the National CFC Phase-out Plan (NCPP) 1 Developing the Transition Strategy Findings of the study of the MDIs

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Loughborough, United Kingdom Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into

More information

Therapeutic products for respiratory and autoimmune diseases. Annual General Meeting

Therapeutic products for respiratory and autoimmune diseases. Annual General Meeting Therapeutic products for respiratory and autoimmune diseases Annual General Meeting November 2007 Summary Objective Lead products Discovery Listings Location Facility Employees Cash (30/6/07) Shares outstanding

More information

Drug/Device Combination Products: Bioequivalence

Drug/Device Combination Products: Bioequivalence Drug/Device Combination Products: Bioequivalence Three stories:. The story of Nasal and Inhalation Product BE 2. The story of the Generic Auto-Injector 3. The story of User Interface Considerations Bioequivalence

More information

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE WHO WE ARE PORTUGUESE WE OFFER Licensing out Contract Manufacturing Packaging Services EU Batch Release R&D Services Marketing & Distribution Medinfar is a fully integrated Pharmaceutical Company with

More information

Boehringer Ingelheim and investment in R&D. Volker Barkmann

Boehringer Ingelheim and investment in R&D. Volker Barkmann Boehringer Ingelheim and investment in R&D Volker Barkmann I. Our Corporation Boehringer Ingelheim in brief Boehringer Ingelheim Center Our headquarters in Ingelheim, Germany Family-owned global corporation

More information

Injection Dosage Calculations

Injection Dosage Calculations INJECTIONS: QUIZ 3 Injection Dosage Calculations 1. A child is ordered 9 mg of gentamicin by IM. Stock ampoules contain 20 mg in 2 ml. What volume is needed for the injection? a. 0.9 ml b. 0.5 ml c. 2.2

More information

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution) Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution) This document should not be treated as a comprehensive guideline; it serves as a

More information

OPPORTUNITIES FOR OMEGA-3 PRODUCTS

OPPORTUNITIES FOR OMEGA-3 PRODUCTS OPPORTUNITIES FOR OMEGA-3 PRODUCTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com

More information

Price List Effective 1June 2011.

Price List Effective 1June 2011. Price List Effective 1June 2011. Price list updated - new product Nexiam 10 mg sachets. NAPPI SCH PRODUCT PACK ANTIBIOTICS MERONEM 820636010 S4 Meronem 500mg vials 1 Vial R 229.20 R 261.29 820644013 S4

More information

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS: 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle

More information

innovative products. faster to market. reliably supplied.

innovative products. faster to market. reliably supplied. innovative products. faster to market. reliably supplied. consumer health E DEVELOPMENT DELIVERY SUPPLY We create unique, tailored consumer health solutions to help your brand grow. With more differentiated

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog March 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic

More information

Release of the 2013/14 Invitation to Tender

Release of the 2013/14 Invitation to Tender 07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive

More information

THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability

THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability International Federation of Pharmaceutical Manufacturers & Associations THE COMPLEX JOURNEY

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

Buprenorphine pharmacology

Buprenorphine pharmacology Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog April 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

Prescribing guidelines: Management of COPD in Primary Care

Prescribing guidelines: Management of COPD in Primary Care Prescribing guidelines: Management of COPD in Primary Care Establish diagnosis of COPD in patients 35 years with appropriate symptoms with history, examination and spirometry (FEV1/FVC ratio < 70%) Establish

More information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST tlo_seledyn.pdf 1 22.08.2017 14:38:01 PRODUCT NAME PHARMACEUTICAL FORM STRENGTH REFERENCE THERAPEUTIC CLASS ALIMENTARY TRACT & METABOLISM

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Purity Product Catalog December 2018 nephronpharm.com 1 (844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and

More information

TRANSDERMAL INNOVATION

TRANSDERMAL INNOVATION TRANSDERMAL INNOVATION 2 TRANSDERMAL MILESTONES Success starts with a vision. An idea that will make a difference. A goal you never lose sight of. At LTS, this goal has always been clear: To offer alternatives

More information

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016 Understanding Regulatory Global Requirements for Nasal Drug Products Julie D. Suman, Ph.D. April 8, 2016 AGENDA NDA vs ANDA Regulatory Approaches for Bioequivalence (BE) FDA Drug Specific Guidances FDA,

More information

THE DOSING SPECIALIST

THE DOSING SPECIALIST 04 THE DOSING SPECIALIST THE COMPANY WHO ARE WE? Over the past 30 years, ROVIPHARM has become the specialist manufacturer of medical and dosing devices for the pharmaceutical and healthcare industries.

More information

Biological Addictions Treatment. Psychology 470. Many Types of Approaches

Biological Addictions Treatment. Psychology 470. Many Types of Approaches Many Types of Approaches Biological Addictions Treatment Psychology 470 Introduction to Chemical Additions Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Detoxification approaches

More information

GUIDANCE DOCUMENT Non-prescription Oral Adult Nasal Decongestant Labelling Standard

GUIDANCE DOCUMENT Non-prescription Oral Adult Nasal Decongestant Labelling Standard GUIDANCE DOCUMENT Decongestant Labelling Standard Published by authority of the Minister of Health Date Adopted 2015/12/17 Effective Date 2015/12/31 Health Products and Food Branch Our mission is to help

More information

PARENTERAL PREPARATIONS

PARENTERAL PREPARATIONS PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through

More information

innovative products. faster to market. reliably supplied.

innovative products. faster to market. reliably supplied. innovative products. faster to market. reliably supplied. consumer health unique consumer health solutions for otc, supplements & beauty DEVELOPMENT DELIVERY SUPPLY As a global leader in the development

More information

LIST OF DRUGS DURING 2004

LIST OF DRUGS DURING 2004 LIST OF DRUGS DURING 2004 S.NO Name Of Drug Pharmacological Classification Date of Approval 188 Dutasteride For BPH 16-02-2004 189 Gefitinib Anti-cancer 17-02-2004 190 Imidapril Anti-hypertensive 23-02-2004

More information

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers! 1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical

More information

Value growth in Human Nutrition & Health

Value growth in Human Nutrition & Health Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with

More information

MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-

MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- November 29, 2018 EA Pharma Co., Ltd. Eisai Co., Ltd. Mochida Pharmaceutical Co., Ltd. MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- EA Pharma

More information

No. Description Packing UOM

No. Description Packing UOM Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC

More information

Technical Monograph n 17, 2nd Edition. Guidelines for Specifying the Shelf Life of Plant Protection Products

Technical Monograph n 17, 2nd Edition. Guidelines for Specifying the Shelf Life of Plant Protection Products Technical Monograph n 17, 2nd Edition Guidelines for Specifying the Shelf Life of Plant Protection Products June 2009 TABLE OF CONTENTS 1. Introduction 3 2. Background 3 3. Definitions 4 4. Outline of

More information

MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA

MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA Document No.: MCA/NSG/17/11/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017

More information

GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003

GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003 EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)

More information

Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004

Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004 Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004 Disclaimer 2 This presentation contains forward-looking statements, i.e., current estimates or expectations

More information

For personal use only

For personal use only 28 May 2015 PYL AND MMJ ON TRACK FOR REVENUES IN JULY Highlights: Production of MMJ s GMP-produced CBD food supplement capsules commenced 25 May 2015 Capsules to be branded and sold as Sativol TM Sativol

More information

Stabilized Rice Bran Nutraceuticals & Functional Food The Road to Healthy Aging

Stabilized Rice Bran Nutraceuticals & Functional Food The Road to Healthy Aging Stabilized Rice Bran Nutraceuticals & Functional Food The Road to Healthy Aging By: Salma A. Helal Managing Director; Health Tech for Integrated Health Solutions 2nd MedSpring brokerage and venturing event

More information

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS Poonam Sheth, PharmD, PhD, Research Scientist, Inhalation Matthew T. Marmura, Research Scientist, Inhalation Recipharm is frequently asked to help

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

Decentralised Procedure. Public Assessment Report. Buprenorphine SUN 2 mg/ 8 mg Sublingual tablets Buprenorphine hydrochloride DE/H/1577/ /DC

Decentralised Procedure. Public Assessment Report. Buprenorphine SUN 2 mg/ 8 mg Sublingual tablets Buprenorphine hydrochloride DE/H/1577/ /DC Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report Buprenorphine SUN 2 mg/ 8 mg Sublingual tablets Buprenorphine hydrochloride DE/H/1577/001-002/DC Applicant:

More information

N a s d a q : I N S Y

N a s d a q : I N S Y N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Mild Cognitive Impairment - Pipeline Review, H1 2017

Mild Cognitive Impairment - Pipeline Review, H1 2017 Report Information More information from: https://www.wiseguyreports.com/reports/1184709-mild-cognitive-impairment-pipeline-review-h1-2017 Mild Cognitive Impairment - Pipeline Review, H1 2017 Report /

More information

BUILDING BUSINESS THROUGH SYNERGY

BUILDING BUSINESS THROUGH SYNERGY BUILDING BUSINESS THROUGH SYNERGY BioAktive Specialty Products is a supplier of ingredients for use in personal care and nutrition. With a presence in both Europe and Asia we work with our distribution

More information

Location of HENGRUI. The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China

Location of HENGRUI. The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China 1 Location of HENGRUI The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China 2 Domestic Achievements No. 1 in Market Cap No. 1 in Innovation No. 1

More information

DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:

DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS: UHS FC: 8703417 Dr. Marilyn Reaño 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic 120 btl 70.00 8,400.00 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic 240 btl 70.00 16,800.00

More information

Advance Notification of Amendments to the December 2018 Drug Tariff

Advance Notification of Amendments to the December 2018 Drug Tariff Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen

More information

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider Boehringer Ingelheim Biopharmaceuticals in China Your Reliable Contract Manufacturing Solution Provider Dr. Bin Wang, Dr. Axel Schleyer Boehringer Ingelheim Biopharmaceuticals (China) Co., Ltd. Contact:

More information

Fundamentals of Pharmacology for Veterinary Technicians Chapter 1

Fundamentals of Pharmacology for Veterinary Technicians Chapter 1 1906 1914 1933 1937 1938 1941 1951 1965 1968 1970 1970 1972 1972 1983 1984 1988 1994 1994 1996 1997 2001 2003 2008 The original Pure Food and Drug Act is passed by Congress on June 30 and signed by President

More information

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Q4 MHS PDL Changes Provider Notice The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Table 1: Summary of Medicaid PDL Additions

More information

The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers. Paul Krajnik UNIDO, Montreal Protocol Branch

The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers. Paul Krajnik UNIDO, Montreal Protocol Branch The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers Paul Krajnik UNIDO, Montreal Protocol Branch 1 The Montreal Protocol Binding international agreement for the preservation and

More information

A world leader in allergy immunotherapy

A world leader in allergy immunotherapy A world leader in allergy immunotherapy Company presentation Per Plotnikof, VP Corporate Communications and IR 1 I ALK at a glance Commercial leader and foremost innovator within respiratory allergies

More information

Memree. Supports Cognitive Function and Stress Reduction. Memree. Nutrition

Memree. Supports Cognitive Function and Stress Reduction. Memree. Nutrition Nutrition Memree Supports Cognitive Function and Stress Reduction Memree for Human Nutrition English Memree Memree contains high-quality soy phosphatidylserine and is a trademark of Lonza Ltd, Switzerland.

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

Decentralised Procedure. Public Assessment Report. Memantin AbZ 10 mg/20 mg Filmtabletten ; Starterpack

Decentralised Procedure. Public Assessment Report. Memantin AbZ 10 mg/20 mg Filmtabletten ; Starterpack Decentralised Procedure Public Assessment Report Memantin AbZ 10 mg/20 mg Filmtabletten ; Starterpack Memantin-ratiopharm Starterpackung 5 mg /10 mg /15 mg /20 mg Filmtabletten ;10 mg/20 mg Filmtabletten

More information

DUAL CHAMBER SYSTEMS

DUAL CHAMBER SYSTEMS DUAL CHAMBER SYSTEMS HEALTH is the inestimable value to which Pharmaceutical Industry is committed. BORMIOLI PHARMA contributes to this mission by following the same values that guide this industry: quality,

More information

Ensuring an Adequate Stockpile of Antivirals. Paul Brown F. Hoffmann La-Roche Basel, Switzerland

Ensuring an Adequate Stockpile of Antivirals. Paul Brown F. Hoffmann La-Roche Basel, Switzerland Ensuring an Adequate Stockpile of Antivirals Paul Brown F. Hoffmann La-Roche Basel, Switzerland Vaccines and Antivirals Vaccines provide the best prevention option But there are limitations: Time from

More information

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Reprinted from FDA s website by EAS Consulting Group, LLC Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed

More information

Approximate Cost for Patients

Approximate Cost for Patients Insurance Coverage for Prescriptions Medications that enhance control of pain and symptoms may be costly if patients do not have insurance. In Ontario, the Ontario Drug Benefit (ODB) Program covers prescriptions

More information

2019 Catalog Hospital and Ophthalmology Products and Services

2019 Catalog Hospital and Ophthalmology Products and Services 209 Catalog Hospital and Ophthalmology Products and Services Ophthalmology Ophthalmology Services. No prescription required No minimum order quantity New formulations are continually added to our portfolio.

More information

Challenges in Developing Stable and Efficient Probiotic Formulations

Challenges in Developing Stable and Efficient Probiotic Formulations Challenges in Developing Stable and Efficient Probiotic Formulations Morgan Laloux morgan.laloux@capsugel.com +32 491 73 20 53 Summary Challenges in Formulating Probiotics Formulating Probiotics in Capsules

More information

Do not open the test booklet prior to being told to do so.

Do not open the test booklet prior to being told to do so. Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources

More information

Company presentation. Claudio Bordignon, Chairman and CEO. Jefferies Global Healthcare Conference New York, 7 June 2012

Company presentation. Claudio Bordignon, Chairman and CEO. Jefferies Global Healthcare Conference New York, 7 June 2012 Company presentation Claudio Bordignon, Chairman and CEO Jefferies Global Healthcare Conference New York, 7 June 2012 Forward-looking statements The presentation contains certain forward-looking statements.

More information

ANIMAL HEALTH DIVISION. Technologies & Services

ANIMAL HEALTH DIVISION. Technologies & Services ANIMAL HEALTH DIVISION Technologies & Services Friulchem AH division is a fully compliant with the EU cgmp. Since 2007, it is a dedicated finished product manufacturer and R&D service provider for the

More information

MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-

MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- This material is an English translation of the press release issued on November 29, 2018 in Japanese,

More information

MEDICATION ASSISTED TREATMENT

MEDICATION ASSISTED TREATMENT MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014 28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some

More information

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016 To support national and global efforts to increase access to and the affordability of HIV/AIDS-related care and treatment together with UNICEF, UNAIDS and UNITAID, invite applicants for selected pharmaceutical

More information

Stockpiling of H5N1 vaccines

Stockpiling of H5N1 vaccines Stockpiling of H5N1 vaccines Norbert W. Hehme EVM Influenza Pandemic Working Group EU-Commission Workshop on Stockpiling of Medicinal Products February 21/22, 2008 European Vaccine Manufacturers 1 (EVM)

More information

Orally Inhaled Corticosteroids to 2022

Orally Inhaled Corticosteroids to 2022 Greystone Research Associates 1+603-595-4340 April 2015 Orally Inhaled Corticosteroids to 2022 Drugs, Devices, Markets and Forecasts Contents A Comprehensive Market Analysis Report Scope & Overview 2 Table

More information

Welcome to Galenicum! APRIL, 2013

Welcome to Galenicum! APRIL, 2013 Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who

More information

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Where positive identification meets safe, efficient patient care. Improve Patient Safety with Accurate Medication Labeling

More information

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31). Product-specific FDA guidance, and product-specific pharmacopeial monographs, point to the use of test equipment, some of which isn t included in the general USP/Ph. Eur. chapters for orally inhaled products

More information

Industry Post-Regulation. E-Cigarette Summit Tim Phillips, ECigIntelligence. 17 th November

Industry Post-Regulation. E-Cigarette Summit Tim Phillips, ECigIntelligence. 17 th November Industry Post-Regulation E-Cigarette Summit 217 Tim Phillips, ECigIntelligence 17 th November 217 www.ecigintelligence.com Agenda 1 2 3 Post-TPD: Has regulation been a success? Heated Tobacco: a success?

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product

More information

Breathtaking science. Developing respiratory drugs to improve health and quality of life. H.C. Wainwright Global Life Sciences Conference April 2018

Breathtaking science. Developing respiratory drugs to improve health and quality of life. H.C. Wainwright Global Life Sciences Conference April 2018 Breathtaking science Developing respiratory drugs to improve health and quality of life H.C. Wainwright Global Life Sciences Conference April 2018 www.veronapharma.com Forward-Looking Statements This presentation

More information

Opioid Conversion Guidelines

Opioid Conversion Guidelines Opioid Conversion Guidelines March 2015 Gippsland Region Palliative Care Consortium Clinical Practice Group Title Keywords Ratified Opioid, Conversion, Drug, Therapy, Palliative, Guideline, Palliative,

More information

Controlled Delivery of Biologics NBC 22 June 2009

Controlled Delivery of Biologics NBC 22 June 2009 Controlled Delivery of Biologics NBC 22 June 2009 ivery System Overview, Chris Rhodes, Amylin ulatory Perspectives, Mei-Ling Chen,FDA tained Circulation Strategies, Tim Riley, Nektar nsdermal Microporation,

More information

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device 3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose

More information

Singapore OTC Switching Regulation

Singapore OTC Switching Regulation Singapore OTC Switching Regulation Roy Shyng Director, Regulatory Affairs Johnson & Johnson Asia Pacific Pte. Ltd. 10 th WSMI AP Regional Conference: Phuket, Thailand, Oct 014 1 Singapore Drug Forensic

More information

KiOnutrime-CsG The proven weight management tool

KiOnutrime-CsG The proven weight management tool KiOnutrime-CsG The proven weight management tool 2015 KitoZyme. 2015 KitoZyme. All rights All reserved. rights reserved. A proven weight management tool KiOnutrime-CsG is a natural ingredient that is scientifically

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014 31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and

More information

What's Important to Consider When Developing a Complex Generic Drug? September 5, 2018

What's Important to Consider When Developing a Complex Generic Drug? September 5, 2018 What's Important to Consider When Developing a Complex Generic Drug? September 5, 2018 Session Description FDA has provided drug manufacturers tools to assist the development of complex generic drugs to

More information